BioIQ Reports Record Growth in 2014 Citing an Increased Demand for its Web-based Health Improvement Platform

Mar 18, 2015

BioIQ, a healthcare technology company, today announced record growth and expansion during 2014, revealing significant developments in the healthcare quality and corporate wellness sectors.

Strong demand for BioIQ’s Software as a Service (SaaS) platform products came mostly from hospitals, health plans and the HEDIS and Star ratings quality sector. Many prominent health plans, Accountable Care Organizations, and Medicare Advantage programs are stepping up their efforts to close clinical gaps in care as required by the Affordable Care Act (ACA). BioIQ’s products are quickly becoming the go-to solution to help companies comply with ACA requirements and increase HEDIS scores because of their ease of implementation, broad set of integrated solutions, and user-friendly interface.

BioIQ also reported rising demand in the corporate wellness market, having launched wellness programs for numerous Fortune 500 companies in just about every industry including manufacturing, technology, retail, healthcare, consulting, finance, government, banking, and finance, amongst others. “The trend is clear: companies and organizations across all industries see the value in programs that can measure and improve population health,” said Justin Bellante, BioIQ’s chief executive officer. “Wellness has moved front and center as employers launch programs to help their employees detect, mitigate, and circumvent chronic conditions such as diabetes, cancer, and heart disease.”

BioIQ also reported a shift in the way patients receive diagnostic care. Large retail pharmacy chains in the United States use BioIQ’s SaaS health improvement platform to conduct biometric screenings and integrate lab results. “In-store screening solutions are convenient for patients,” Bellante said. “They also help pharmacies forge stronger relationships with customers and drive additional foot traffic into their stores.”

BioIQ was recently selected number 94 in Deloitte Consulting’s 2014 Technology Fast 500. BioIQ customers and partners will continue to benefit from this growth as BioIQ invests its capital into innovations that enhance customer and partner support, solutions, and experiences.

Back to Media